[Remote] Sr. Territory Account Manager, Shanghai at Illumina

Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Genomics, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree and demonstrate at least five years of experience in sales, with a strong familiarity with the East China market and a proven track record of driving sales objectives. They should be adept at developing high-value customer accounts, utilizing CRM databases, and providing accurate sales forecasts.

Responsibilities

The Sr. Territory Account Manager will represent the company professionally, ethically, and morally, develop high-value customer accounts through the sale of Illumina’s products and services, participate in sales activities, coordinate sales activities, develop and maintain account details in the CRM database, provide regular sales forecast updates, assist with territory planning, maintain relationships with internal customers and product development groups, establish a comprehensive database of users, spend at least 40% of their time in the field, negotiate genetic analysis sales, assist with identifying new sales people, aid in the development of new sales territories, and support marketing activities.

Skills

Customer Relationship Management (CRM)

Sales Strategy

Account Management

Customer Support

Territory Planning

Communication

Time Management

Product Knowledge

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free